Sharenet Sites 
Sharenet Sites
Directors dealings
ASCENDIS HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2008/005856/06)
ISIN: ZAE000185005 Share code: ASC
(“Ascendis”)
Dealings in securities by directors
In terms of paragraphs 3.63 to 3.65 of the JSE Limited (“the JSE”) Listings Requirements ("the Listings
Requirements"), the following information, relating to dealings in securities by directors, is disclosed:
Directors: Gary John Shayne and Crispian Dillon
Nature of the transaction: Investors are referred to the announcement by
Ascendis on 17 December 2013 regarding: (a) an
acquisition by Ascendis which fell below the
category two transaction threshold as defined in the
Listings Requirements (”Acquisition”) and therefore
was not disclosed separately, as well as (b) the
option agreement entered into between the acquired
company’s vendors (“Vendors”) and Gane Holdings
Proprietary Limited (“Gane Holdings”) (previously
named Bounty Brands Proprietary Limited)
(“Option”).
Subsequent to the conclusion of the Acquisition,
Ascendis and a relevant Vendor (“Vendor”) have
agreed to adjust a deferred portion of the purchase
consideration. As such, the Vendor has agreed to
reimburse Ascendis R3 922 576.
Additionally 354 473 ordinary Ascendis shares
(“Ascendis Shares”), which were issued to the
Vendor and which represented a portion of the
purchase consideration subject to the Option, will be
transferred from the Vendor to Gane Holdings as an
early vesting of a portion of the Option.
Gary Shayne holds an 85% indirect interest in Gane
Holdings and Crispian Dillon holds a 15% indirect
interest in Gane Holdings.
Number of Ascendis Shares 354,473
transferred to Gane Holdings:
Price A nominal amount of R100 was paid to effect the
early vesting of the applicable portion of the Option.
Deemed transaction value: Nominal transaction value of R100
Extent of interest: Indirect beneficial (through Gane Holdings), in which
Gary Shayne has a 85% indirect beneficial interest
and Crispian Dillon has a 15% indirect beneficial
interest)
Written clearance obtained: Clearance was obtained from the Chairman
24 September 2014
Johannesburg
Sponsor
Investec
Date: 25/09/2014 01:37:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
